The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictive and prognostic significance of PIOS (Patras Immunotherapy Score) model in patients with advanced NSCLC treated with nivolumab or pembrolizumab: Results from a validation cohort.
 
Foteinos-Ioannis D. Dimtrakopoulos
Research Funding - Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Roche
 
Giannis Socrates Mountzios
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Pfizer; Roche; Takeda
 
Petros Christopoulos
Honoraria - AstraZeneca; Boehringer Ingelheim; Boehringer Ingelheim; Chugai Pharma; Novartis; Pfizer; Roche; Takeda
Research Funding - AstraZeneca (Inst); Roche (Inst); Takeda (Inst)
 
Thomas Papastergiou
No Relationships to Disclose
 
Eleftherios Zervas
Consulting or Advisory Role - MSD; Roche
 
Sofia Agelaki
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Pfizer; Roche; Takeda
 
Epaminondas Samantas
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Pfizer; Roche
 
Ilias Athanasiadis
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Pfizer; Roche
 
Sofia Baka
Consulting or Advisory Role - AstraZeneca; BMS; Boehringer Ingelheim; MSD Oncology; Novartis; Roche
Research Funding - AstraZeneca; BMS; Boehringer Ingelheim; Genesis Pharmaceuticals; Lilly; MSD Oncology; Novartis; Takeda
Travel, Accommodations, Expenses - BMS; Boehringer Ingelheim; Demo Pharmaceutical; MSD
 
Kostas N. Syrigos
Honoraria - Bristol-Myers Squibb; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; Roche
Research Funding - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Roche
 
Athina Christopoulou
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; MSD; Pfizer; Roche
 
Evangelos Lianos
Consulting or Advisory Role - AstraZeneca; MSD; Pfizer; Roche
 
Nikolaos Tsoukalas
No Relationships to Disclose
 
Eleni Isidora Perdikouri
No Relationships to Disclose
 
Georgios Oikonomopoulos
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Roche
 
Foteini Kalofonou
No Relationships to Disclose
 
Thomas Makatsoris
Honoraria - AstraZeneca; Genesis Pharma; Ipsen; Merck; MSD; Sanofi
 
Angelos Koutras
Consulting or Advisory Role - Pierre Fabre
Travel, Accommodations, Expenses - Genesis Pharmaceuticals; Ipsen; MSD
 
Vasileios Megalooikonomou
No Relationships to Disclose
 
Haralabos Kalofonos
Consulting or Advisory Role - Amgen; EMD Serono; Genesis Pharma; Janssen Biotech; Leo Pharma; Lilly; MSD/Merck; Novartis; Pfizer; Roche
Research Funding - Amgen; Bayer; EMD Serono; Genesis Pharma; Janssen Biotech; Lilly; MSD/Merck; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer; Roche